Key Metrics
7.8
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
5 - 10
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
35
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
0.82
5-Year SI
5-year SI
- N/A 2-year SI
- 0.83 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q1
Pharmacology (medical)
SJR
- Q1 Pharmacology (medical)
- Q1 Cardiology and Cardiovascular Medicine
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
1.61
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
3 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
68%
4 to 6 months
30%
7 to 9 months
1%
Above 9 months
0%
Did you find this useful?
Thank you for your feedback.
Topics Covered
- Myocardial infarction
- Kidney disease
- Atrial fibrillation
- Aspirin
- Heart failure
- Confidence interval
- Rivaroxaban
- Colchicine
- Percutaneous coronary intervention
- Cardiovascular outcomes
- Major bleeding
- Anticoagulant
- Ticagrelor
- Apixaban
- Pooled analysis
- Blood pressure
- Nonsteroidal
- Liver disease
- Ejection fraction
- Hazard ratio
Journal Specifications
| Overview | |
| Publisher | OXFORD UNIV PRESS |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2015 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in European Heart Journal - Cardiovascular Pharmacotherapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Lipid lowering therapies for aortic stenosis: a drug-target Mendelian randomisation study.
- 28 Nov 24
- European heart journal. Cardiovascular pharmacotherapy
-
Full paper
STOPDAPT-3 subanalysis on prasugrel monotherapy after elective or emergent coronary intervention in patients with or without diabetes: are we ready for this?
- 19 Nov 24
- European heart journal. Cardiovascular pharmacotherapy
-
Full paper
Pharmacogenetic testing to broaden patient eligibility for mavacamten.
- 14 Nov 24
- European heart journal. Cardiovascular pharmacotherapy
-
Full paper
Cost-effectiveness of Implementing a Genotype-Guided De-Escalation Strategy in Patients with Acute Coronary Syndrome.
- 13 Nov 24
- European heart journal. Cardiovascular pharmacotherapy
-
Full paper
Extensive LDL-cholesterol lowering by PCSK9 inhibitor on the risk of venous thrombosis.
- 8 Nov 24
- European heart journal. Cardiovascular pharmacotherapy
-
Full paper
Subcutaneous furosemide in heart failure: a systematic review.
- 8 Nov 24
- European heart journal. Cardiovascular pharmacotherapy
Scite analysis
Powered by scite_
776 articles received 7.9k citations see all
- 304 Supporting
- 7,195 Mentioning
- 62 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 0 Corrections
- 37 Errata
- 0 Expression of Concern
FAQs
How long has European Heart Journal - Cardiovascular Pharmacotherapy been actively publishing?
European Heart Journal - Cardiovascular Pharmacotherapy has been in operation since 2015 till date.
What is the publishing frequency of European Heart Journal - Cardiovascular Pharmacotherapy ?
European Heart Journal - Cardiovascular Pharmacotherapy published with a Bi-monthly frequency.
How many articles did European Heart Journal - Cardiovascular Pharmacotherapy publish last years ?
In 2023, European Heart Journal - Cardiovascular Pharmacotherapy published 100 articles.
What is the eISSN & pISSN for European Heart Journal - Cardiovascular Pharmacotherapy ?
For European Heart Journal - Cardiovascular Pharmacotherapy,eISSN is 2055-6845 and pISSN is2055-6837.
What is Citescore for European Heart Journal - Cardiovascular Pharmacotherapy ?
Citescore for European Heart Journal - Cardiovascular Pharmacotherapy is 7.8.
What is H index for European Heart Journal - Cardiovascular Pharmacotherapy ?
H index for European Heart Journal - Cardiovascular Pharmacotherapy is 35.
What is SNIP score for European Heart Journal - Cardiovascular Pharmacotherapy ?
SNIP score for European Heart Journal - Cardiovascular Pharmacotherapy is 1.61.
What is the SJR for European Heart Journal - Cardiovascular Pharmacotherapy ?
SJR for European Heart Journal - Cardiovascular Pharmacotherapy is Q1.
Who is the publisher of European Heart Journal - Cardiovascular Pharmacotherapy ?
OXFORD UNIV PRESS is the publisher of European Heart Journal - Cardiovascular Pharmacotherapy.